Cargando…

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study

OBJECTIVES: Little is known regarding the ‘false-negative’ or ‘false-positive’ striatal dopamine transporter binding on SPECT for the diagnosis of dementia with Lewy bodies (DLB). We explored the clinical course in patients fulfilling the criteria for clinical DLB with a normal ((123)I)FP-CIT SPECT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siepel, Françoise J, Rongve, Arvid, Buter, Tirza C, Beyer, Mona K, Ballard, Clive G, Booij, Jan, Aarsland, Dag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641475/ https://www.ncbi.nlm.nih.gov/pubmed/23572198 http://dx.doi.org/10.1136/bmjopen-2013-002642

Ejemplares similares

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An (123)I-FP-CIT SPECT study
por: van der Zande, J.J., et al.
Publicado: (2019)

Imaging of serotonin transporters with [(123)I]FP-CIT SPECT in the human hypothalamus
por: Borgers, Anke J, et al.
Publicado: (2013)

(123)I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies
por: Pardini, Matteo, et al.
Publicado: (2020)

[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies
por: van der Zande, J. J., et al.
Publicado: (2016)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT
por: Matsuda, Hiroshi, et al.
Publicado: (2018)

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
por: Walker, Zuzana, et al.
Publicado: (2016)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
por: D’agostino, G., et al.
Publicado: (2023)

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An (123)I-FP-CIT SPECT study
por: Joling, Merijn, et al.
Publicado: (2019)

Assessing Nigrostriatal Dopaminergic Pathways via 123I-FP-CIT SPECT in Dementia With Lewy Bodies in a Psychiatric Patient Cohort
por: Hansen, Niels, et al.
Publicado: (2021)

Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT
por: Eklund, Mikael, et al.
Publicado: (2022)

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [(123)I]FP-CIT SPECT imaging
por: Dickson, John C., et al.
Publicado: (2017)

Clinical evaluation of [(123)I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison
por: Adriaanse, Sofie M., et al.
Publicado: (2018)

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
por: Rahman, Mahmudur G. M., et al.
Publicado: (2018)

A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
por: Rahman, Mahmudur G. M., et al.
Publicado: (2020)

A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [(123)I]I-FP-CIT SPECT in routine practice
por: Chahid, Youssef, et al.
Publicado: (2023)

Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
por: Joling, Merijn, et al.
Publicado: (2018)

(123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component
por: Garriga, Marina, et al.
Publicado: (2015)

Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT
por: Nonokuma, Masanari, et al.
Publicado: (2016)

Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
por: Jeong, Eun Hye, et al.
Publicado: (2022)

Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration
por: Akahoshi, Miho, et al.
Publicado: (2017)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [(123)I]FP-CIT SPECT/CT Brain Imaging
por: Vu, Jeanne P., et al.
Publicado: (2021)

Specific Binding Ratio Estimation of [(123)I]-FP-CIT SPECT Using Frontal Projection Image and Machine Learning
por: Kita, Akinobu, et al.
Publicado: (2023)

[(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods
por: Tossici-Bolt, Livia, et al.
Publicado: (2017)

Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients
por: Hida, Kosuke, et al.
Publicado: (2016)

Combination of compressed sensing-based iterative reconstruction and offset acquisition for I-123 FP-CIT SPECT: a simulation study
por: Matsutomo, Norikazu, et al.
Publicado: (2022)

Effect of cerebrospinal fluid area mask correction on (123)I-FP-CIT SPECT images in idiopathic normal pressure hydrocephalus
por: Ohba, Makoto, et al.
Publicado: (2023)

Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
por: Thomas, Alan J., et al.
Publicado: (2017)

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
por: Thomsen, Gerda, et al.
Publicado: (2013)

Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease
por: Suwijn, Sven R., et al.
Publicado: (2019)

Comparison of [(18)F]-FDOPA PET and [(123)I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
por: Wallert, Elon, et al.
Publicado: (2022)

Validation of Optimum ROI Size for (123)I-FP-CIT SPECT Imaging Using a 3D Mathematical Cylinder Phantom
por: Onishi, Hideo, et al.
Publicado: (2018)

Parkinsonism Associated with Pathological 123I-FP-CIT SPECT (DaTSCAN) Results as the Initial Manifestation of Sporadic Creutzfeldt-Jakob Disease
por: Carrasco García de León, Sira, et al.
Publicado: (2018)

Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease – An Unexpected Finding?
por: Bittner, Verena, et al.
Publicado: (2011)

Computer-aided diagnosis for ((123)I)FP-CIT imaging: impact on clinical reporting
por: Taylor, Jonathan Christopher, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gojtmj8tljbmcebfqngul7qfoe